-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
NewAmsterdam Pharma Co N.V. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2023.
- NewAmsterdam Pharma Co N.V. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$16.6M, a 64.7% increase year-over-year.
- NewAmsterdam Pharma Co N.V. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$199M.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2023 was -$177M, a 682% decline from 2022.
- NewAmsterdam Pharma Co N.V. annual Net Income (Loss) Attributable to Parent for 2022 was -$22.6M, a 45.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)